BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 27440897)

  • 1. MORC3, a Component of PML Nuclear Bodies, Has a Role in Restricting Herpes Simplex Virus 1 and Human Cytomegalovirus.
    Sloan E; Orr A; Everett RD
    J Virol; 2016 Oct; 90(19):8621-33. PubMed ID: 27440897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Human Cytomegalovirus IE1 Leads to Accumulation of Mono-SUMOylated PML That Is Protected from Degradation by Herpes Simplex Virus 1 ICP0.
    Hou W; Cruz-Cosme R; Wen F; Ahn JH; Reeves I; Luo MH; Tang Q
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30258013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the functional interchange between the IE1 and pp71 proteins of human cytomegalovirus and ICP0 of herpes simplex virus 1.
    Lu Y; Everett RD
    J Virol; 2015 Mar; 89(6):3062-75. PubMed ID: 25552717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of the Replication of ICP0-Null Mutant Herpes Simplex Virus 1 and pp71-Deficient Human Cytomegalovirus by Epstein-Barr Virus Tegument Protein BNRF1.
    Lu Y; Orr A; Everett RD
    J Virol; 2016 Nov; 90(21):9664-9673. PubMed ID: 27535048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.
    Brown JR; Conn KL; Wasson P; Charman M; Tong L; Grant K; McFarlane S; Boutell C
    J Virol; 2016 Jul; 90(13):5939-5952. PubMed ID: 27099310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection.
    Glass M; Everett RD
    J Virol; 2013 Feb; 87(4):2174-85. PubMed ID: 23221561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The viral ubiquitin ligase ICP0 is neither sufficient nor necessary for degradation of the cellular DNA sensor IFI16 during herpes simplex virus 1 infection.
    Cuchet-Lourenço D; Anderson G; Sloan E; Orr A; Everett RD
    J Virol; 2013 Dec; 87(24):13422-32. PubMed ID: 24089555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The replication defect of ICP0-null mutant herpes simplex virus 1 can be largely complemented by the combined activities of human cytomegalovirus proteins IE1 and pp71.
    Everett RD; Bell AJ; Lu Y; Orr A
    J Virol; 2013 Jan; 87(2):978-90. PubMed ID: 23135716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic Response of IFI16 and Promyelocytic Leukemia Nuclear Body Components to Herpes Simplex Virus 1 Infection.
    Everett RD
    J Virol; 2016 Jan; 90(1):167-79. PubMed ID: 26468536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response.
    Conn KL; Wasson P; McFarlane S; Tong L; Brown JR; Grant KG; Domingues P; Boutell C
    J Virol; 2016 May; 90(9):4807-4826. PubMed ID: 26937035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct temporal roles for the promyelocytic leukaemia (PML) protein in the sequential regulation of intracellular host immunity to HSV-1 infection.
    Alandijany T; Roberts APE; Conn KL; Loney C; McFarlane S; Orr A; Boutell C
    PLoS Pathog; 2018 Jan; 14(1):e1006769. PubMed ID: 29309427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of SUMO-SIM Interaction on the ICP0-Mediated Degradation of PML Isoform II and Its Associated Proteins in Herpes Simplex Virus 1 Infection.
    Jan Fada B; Kaadi E; Samrat SK; Zheng Y; Gu H
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32295906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation.
    Cuchet-Lourenço D; Vanni E; Glass M; Orr A; Everett RD
    J Virol; 2012 Oct; 86(20):11209-22. PubMed ID: 22875967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two overlapping regions within the N-terminal half of the herpes simplex virus 1 E3 ubiquitin ligase ICP0 facilitate the degradation and dissociation of PML and dissociation of Sp100 from ND10.
    Perusina Lanfranca M; Mostafa HH; Davido DJ
    J Virol; 2013 Dec; 87(24):13287-96. PubMed ID: 24089549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx.
    Lukashchuk V; Everett RD
    J Virol; 2010 Apr; 84(8):4026-40. PubMed ID: 20147399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential functions of interferon-upregulated Sp100 isoforms: herpes simplex virus type 1 promoter-based immediate-early gene suppression and PML protection from ICP0-mediated degradation.
    Negorev DG; Vladimirova OV; Maul GG
    J Virol; 2009 May; 83(10):5168-80. PubMed ID: 19279115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PML plays both inimical and beneficial roles in HSV-1 replication.
    Xu P; Mallon S; Roizman B
    Proc Natl Acad Sci U S A; 2016 May; 113(21):E3022-8. PubMed ID: 27162364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0.
    Everett RD; Rechter S; Papior P; Tavalai N; Stamminger T; Orr A
    J Virol; 2006 Aug; 80(16):7995-8005. PubMed ID: 16873256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MORC3 restricts human cytomegalovirus infection by suppressing the major immediate-early promoter activity.
    Ma XH; Yao YX; Wang XZ; Zhou YP; Huang SN; Li D; Mei MJ; Wu JP; Pan YT; Cheng S; Jiang X; Sun JY; Zeng WB; Gong S; Cheng H; Luo MH; Yang B
    J Med Virol; 2022 Nov; 94(11):5492-5506. PubMed ID: 35879101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100.
    Everett RD; Parada C; Gripon P; Sirma H; Orr A
    J Virol; 2008 Mar; 82(6):2661-72. PubMed ID: 18160441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.